This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

20 Apr 2020

Hovione's 'world's first' innovative inhaler receives prestigious design award

The 8Shot DPI is capable of delivering high doses of drug to the lungs.

Hovione Technology's 8Shot dry powder inhaler (DPI) enabling high dose drug delivery to the lungs has received the Red Dot 2020 Product Design Award in the Healthcare Daily Living AIDS category.

8Shot is the world’s first 8-puff, disposable DPI enabling drug delivery of new pharmaceutical compounds requiring very high doses delivered to the lungs.

The device is suitable for inhaled delivery of biologics, antibiotics, anti-viral, vaccines, pain or rescue treatments of doses up to 400 mg formulated as drug alone or engineered particles in multiple, sequential inhalation maneuvers for maximum therapeutic benefit and patient safety.

“We are extremely proud and delighted to accept the Red Dot Product Design Award, together with our design and development partner WeADD,” said Dr João Ventura Fernandes, Hovione Technology’s Director of Technology Development and Licensing.

“The 8Shot DPI is uniquely positioned to make available off-the-shelf to pharmaceutical companies a patented high payload DPI to deliver inhaled biologics, antibiotics, anti-virals, vaccines, pain or rescue treatments requiring high-dose drug delivery.”

Mentioned Companies
Hovione FarmaCiencia SA
View company profile

Related News